2022
Feb.
Test laboratory Qualified "A" grade obtained.
Dec.
GenomomAI(NIPT) service launch.
2021
Feb.
Test laboratory Qualified "A" grade obtained.
2020
May.
Cost-Effective Method to Measure Fetal Fraction by Adaptive Multiple Regression Techniques with Optimally Selected Autosomal Chromosome Regions(Paper Published IEEE)
2019
Dec
New-born screening by
research & study MOU
with Big-data center AI team (Sejong University)
Nov.
Liquid Biopsy Cancer Screening research & study
MOU
(Yonsei University Hospital)
Oct.
Genetic Test Laboratory Qualified "A" grade obtained
(upgraded for 2020)
Jun.
Premature birth prediction system development MOU
(Hanlim University Hospital)
Jan.
Moved-in to Newly Integrated Lab & Office
(Gwanggyo Central Biz Tower)
2018
Aug.
NIPT patent 3rd stage approval by KIPO
Jul.
NIPT Tech-Transfer to major hospitals in Korea
(CHA / JEIL Hospitals)
International NIPT patent registered in US
May
GenoBro(PGS) Test Launch
iGenomics genetic test
Licensing-in (ERA,EMMA)
Apr.
1st NGS-PGS Test approval in S.Korea (KCDC)
Jan.
NIPT Tech-Transfer contract in Middle-East countries
2017
May
NIPT patent 2nd stage approval by KIPO
Feb.
GenoMom service contract with PTC in Thailand
2016
Oct.
Published 3rd Clinical Report in SCI-class journal
(BMC Medical Genomics)
Apr.
Published 2nd Clinical Report in SCI-class journal
(BMC Medical Genomics)
NIPT patent registered in KIPO
Jan.
Genetic Test Laboratory approved by KCDC
2015
Nov.
Clinical Laboratory Set-up
Sep.
GenoMom(NIPT) test launch
GenomomTM registered
May
Office move to Gwanggyo
2014
Oct.
Published 1st Clinical Report in SCI-class journal
(PLOS ONE)
2012
Nov.
Company established